VALSARTAN

Generic: VALSARTAN

Dr. Reddy's Laboratories LimitedManufacturer
ORALRoute
VALSARTANActive Substance
2021-10-05Original Approval

VALSARTAN is FDA application ANDA201618, sponsored by DR REDDYS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2018-12-04
Valsartan and Hydrochlorothiazide Tablets, USP 320/25 mg, (a) 90-count bottle (NDC 0378-6325-77), (b) 500-count bottles

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylam

Class II2018-12-04
Valsartan and Hydrochlorothiazide Tablets, USP 160/25 mg, (a) 90-count bottle (NDC 0378-6323-77), (b) 500-count bottles

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylam

Class II2018-12-04
Valsartan and Hydrochlorothiazide Tablets, USP 160/12.5 mg, (a) 90-count bottle (NDC 0378-6322-77), (b) 500-count bottle

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylam

Class II2018-07-13
Solco Healthcare US Valsartan and Hydrochlorothiazide, USP, 160 MG/25 MG Tablets, 90-count bottle, Rx Only, Manufactured

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class II2018-11-20
Amlodipine and Valsartan Tablets, USP,10 mg/160 mg, 30-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pha

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in t

Class II2018-12-04
Valsartan Tablets, USP 320 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc.,

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylam

Class II2018-12-04
Valsartan Tablets, USP 80 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., M

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylam

Class II2017-11-29
Valsartan Tablets, USP, 160 mg, 90-count bottles, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd, Xun

Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in

Class II2018-11-20
Amlodipine and Valsartan Tablets, USP, 10 mg/320 mg, 30-count bottle, Rx Only, Made in India, Manufactured for: Mylan Ph

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in t

Class II2018-12-31
Valsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810.

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in

Top Reported Reactions

1
DRUG INEFFECTIVE
4,093 reports
2
FATIGUE
3,287 reports
3
DYSPNOEA
3,053 reports
4
NAUSEA
3,028 reports
5
DIZZINESS
2,977 reports
6
DIARRHOEA
2,953 reports
7
HEADACHE
2,626 reports
8
ACUTE KIDNEY INJURY
2,533 reports
9
OFF LABEL USE
2,346 reports
10
HYPERTENSION
2,133 reports